Motco Eli Lilly & CO Transaction History

Motco

$991 Million
Q3 2024

A detailed history of Motco transactions in Eli Lilly & CO stock. As of the latest transaction made, Motco holds 13,205 shares of LLY stock, worth $10.5 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares

13,205

Previous 9,059 45.77%

Holding current value

$10.5 Million

Previous $8.2 Million 42.64%

% of portfolio

1.18%

Previous 0.84%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$772.14 - $960.02 $3.2 Million - $3.98 Million	4,146 Added 45.77%	13,205 $11.7 Million
Q2 2024 Aug 07, 2024	SELL	$724.87 - $909.04 $117,428 - $147,264	-162 Reduced 1.76%	9,059 $8.2 Million
Q1 2024 May 09, 2024	BUY	$592.2 - $792.28 $1,184 - $1,584	2 Added 0.02%	9,221 $7.17 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $3.54 Million - $4.17 Million	6,733 Added 270.84%	9,219 $5.37 Million
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $26,082 - $35,958	-60 Reduced 2.36%	2,486 $1.34 Million
Q2 2023 Aug 04, 2023	SELL	$350.74 - $468.98 $5,611 - $7,503	-16 Reduced 0.62%	2,546 $1.19 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $90,082 - $105,797	-290 Reduced 10.17%	2,562 $879,000
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $88,104 - $102,659	-274 Reduced 8.77%	2,852 $1.04 Million
Q3 2022 Nov 03, 2022	BUY	$296.48 - $337.87 $42,989 - $48,991	145 Added 4.86%	3,126 $1.01 Million
Q2 2022 Aug 05, 2022	SELL	$278.73 - $327.27 $779,329 - $915,046	-2,796 Reduced 48.4%	2,981 $967,000
Q1 2022 May 06, 2022	BUY	$234.69 - $291.66 $11,265 - $13,999	48 Added 0.84%	5,777 $1.65 Million
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $86,342 - $107,151	-384 Reduced 6.28%	5,729 $1.58 Million
Q3 2021 Oct 29, 2021	SELL	$221.6 - $272.71 $9,972 - $12,271	-45 Reduced 0.73%	6,113 $1.41 Million
Q2 2021 Aug 04, 2021	SELL	$180.55 - $233.54 $6.41 Million - $8.3 Million	-35,530 Reduced 85.23%	6,158 $1.41 Million
Q1 2021 Apr 16, 2021	SELL	$164.32 - $212.72 $116,174 - $150,393	-707 Reduced 1.67%	41,688 $7.79 Million
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $305,928 - $404,817	-2,345 Reduced 5.24%	42,395 $7.16 Million
Q3 2020 Nov 10, 2020	BUY	$146.22 - $169.13 $40,795 - $47,187	279 Added 0.63%	44,740 $6.62 Million
Q2 2020 Jul 15, 2020	SELL	$136.42 - $164.18 $732,984 - $882,139	-5,373 Reduced 10.78%	44,461 $7.3 Million
Q1 2020 May 06, 2020	SELL	$119.05 - $147.35 $244,766 - $302,951	-2,056 Reduced 3.96%	49,834 $6.91 Million
Q4 2019 Feb 06, 2020	BUY	$106.92 - $132.43 $69,284 - $85,814	648 Added 1.26%	51,890 $6.82 Million
Q3 2019 Nov 05, 2019	BUY	$106.79 - $116.16 $534,911 - $581,845	5,009 Added 10.83%	51,242 $5.73 Million
Q2 2019 Aug 07, 2019	BUY	$110.79 - $129.32 $71,570 - $83,540	646 Added 1.42%	46,233 $5.12 Million
Q1 2019 May 02, 2019	SELL	$111.31 - $131.02 $663,184 - $780,617	-5,958 Reduced 11.56%	45,587 $5.92 Million
Q4 2018 Feb 08, 2019	SELL	$105.9 - $118.64 $242,193 - $271,329	-2,287 Reduced 4.25%	51,545 $5.97 Million
Q3 2018 Nov 07, 2018	BUY	$85.86 - $107.31 $14,939 - $18,671	174 Added 0.32%	53,832 $5.78 Million
Q2 2018 Aug 09, 2018	BUY	$75.7 - $86.88 $6,585 - $7,558	87 Added 0.16%	53,658 $4.58 Million
Q1 2018 May 08, 2018	BUY	$74.21 - $87.6 $3.11 Million - $3.67 Million	41,882 Added 358.3%	53,571 $4.15 Million
Q4 2017 Feb 06, 2018	SELL	$81.94 - $87.89 $32,448 - $34,804	-396 Reduced 3.28%	11,689 $988,000
Q3 2017 Nov 07, 2017	SELL	$77.07 - $85.54 $67,436 - $74,847	-875 Reduced 6.75%	12,085 $1.03 Million
Q2 2017 Aug 08, 2017	BUY	N/A	12,960	12,960 $1.07 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Motco, based on Form 13F filings with the SEC.

News

Stay updated on Motco with notifications on news.

Account